The United Laboratories International Holdings Limited (ULIHF)
OTCMKTS · Delayed Price · Currency is USD
1.640
0.00 (0.00%)
Aug 7, 2025, 8:00 PM EDT
Paramount Global Market Cap
ULIHF has a market cap or net worth of $3.86 billion as of August 11, 2025. Its market cap has increased by 102.41% in one year.
Market Cap
3.86B
Enterprise Value
3.43B
Revenue
1.89B
Ranking
n/a
PE Ratio
10.59
Stock Price
$1.64
Market Cap Chart
Since June 15, 2007, ULIHF's market cap has increased from 554.04M to 3.86B, an increase of 596.33%. That is a compound annual growth rate of 11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 3.80B | 31.52% |
| Dec 31, 2024 | 2.89B | 77.33% |
| Dec 29, 2023 | 1.63B | 42.79% |
| Dec 30, 2022 | 1.14B | 11.63% |
| Dec 31, 2021 | 1.02B | -21.65% |
| Dec 31, 2020 | 1.31B | 9.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 365.69M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.51M |